Cargando…
Evaluation of topical bevacizumab as an adjunct to mitomycin C augmented trabeculectomy
PURPOSE: To investigate the safety and synergistic effect of topical bevacizumab after trabeculectomy surgery with mitomycin C (MMC). METHODS: In this prospective, non-randomized, comparative interventional study, 40 eyes from 40 patients with uncontrolled open-angle glaucoma were studied after they...
Autores principales: | Zarei, Reza, Masoumpour, Masoumeh, Moghimi, Sasan, Fakhraei, Ghasem, Eslami, Yadollah, Mohammadi, Masoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463009/ https://www.ncbi.nlm.nih.gov/pubmed/28626816 http://dx.doi.org/10.1016/j.joco.2016.10.003 |
Ejemplares similares
-
Effect of Mitomycin-C Augmented Trabeculectomy on Corneal Endothelial Cells
por: Zarei, Reza, et al.
Publicado: (2015) -
Subconjunctival bevacizumab to augment trabeculectomy with mitomycin C in the management of failed glaucoma surgery
por: Saeed, Ahmed M, et al.
Publicado: (2014) -
Comparison of the Outcome of Repeat Trabeculectomy with Adjunctive Mitomycin C and Initial Trabeculectomy
por: Cankaya, Ali Bulent, et al.
Publicado: (2011) -
Neovascularization of angle following trabeculectomy augmented with mitomycin-C
por: Shalaby, Wesam Shamseldin, et al.
Publicado: (2021) -
Topical Latanoprost Does Not Cause Macular Thickening after Uncomplicated Cataract Surgery
por: Moghimi, Sasan, et al.
Publicado: (2012)